Key facts
- This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 18:27.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.